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A three-dimensional high-performance liquid chromatography (HPLC) 
method is described for the determination of cyclosporine A in human 
skin. The method allows to determine at least 3 ng cyclosporine A in 10 
mg skin (total sample amount needed) and is suitable for cyclosporine A 
level monitoring in the skin of psoriatic patients. 
HPLC-Bestimmung von Cyclosporin A in menschlicher Haut 
Eine dreidimensionale HPLC-Methode zur Bestimmung von < 3 ng 
Cyclosporin A in 10 mg menschlicher Haut wird beschrieben. Dieses Ver-
fahren eignet sich zur Cyclosporin A Bestimmung in der Haut von Psoria-
tikern. 
Cyclosporine A (CyA) is highly effective in the systemic treatment of 
psoriasis. The mechanism of C y A functioning in skin is not yet fully 
understood, but it is known that topical application has no clinical effect. 
However, by oral or intravenous application dose-related side-effects, 
particularly nephrotoxicity, appeared1). 
The purpose of this work was to develop an analytical 
method that would enable to investigate the relationship 
between the skin CyA level and the antipsoriatic effect by 
oral C y A application. To reduce the stress of the patients, 
the amount of skin sample should not exceed 10-20 mg. 
Several methods of C y A determination in biological 
material were published, mostly based on H P L C or radio-
immunoassay, but only few of them were used for skin 
analysis 1 , 2' 3' 4). A l l these methods are of relatively low sensi-
tivity and require large sample amounts (about 100 mg). 
The C y A skin level was found to be approximately 3.5 
ng/mg wet weight by patients receiving a daily oral dose of 
14 mg/kg 4 ). However, the common therapeutical doses are 
smaller; provided in such case the C y A level is equal to or 
less than 1 ng/mg tissue, the sensitivity required for the 
determination would be 10 ng CyA/sample and less. 
Preliminary solid-phase extraction experiments on the 10 
ng level failed. The skin extract purification step using 
common SPE procedures was not successful due to partial-
ly irreversible adsorption of the C y A on the cartridge. Sev-
eral sorbents were used but the recovery was not reprodu-
cible and mostly less than 50%. Only the multi-dimensional 
H P L C provided the required results. 
Materials and Methods 
Reagents and purity requirements 
Skin extraction: C H 3 C N for spectroscopy (Uvasol, Merck, Darmstadt); 
chromatography: C H 3 C N of gradient H P L C grade (Baker), hexane and 
isopropanol of H P L C grade (Baker); water of LiChrosolv quality (Merck). 
Cyclosporine A (batch No. 90166) and cyclosporine C (CyC, batch No. 
27402) were kindly supplied by Sandoz. The concentrations of stock solu-
tions were 0.94 ng C y A / u l C H 3 C N and 1.115 ng CyC/p l C H 3 C N . 
The samples were handled in 4 ml screwing cap vials with PTFE seal. 
A l l used glass was cleaned with chromosulfuric acid. N 2 used for sample 
evaporation was of 5.0 quality with an all-steel pressure degradation vent. 
Skin extraction 
Skin used for recovery experiments originated from amputation. After 
separation it was frozen and then handled in two ways: 
a) A n approximately 0.5 mm thick upper layer was taken by lancet. 
b) The epidermis only (0.2 mm) was separated by a microtome; the 
separation was controlled by microscopy. 
10-15 mg skin sample and approximately 100 mg quartz sand p.a. were 
placed in a small mortar, cooled with liquid N 2 and homogenized after its 
evaporation. The mortar was let to warm up and the sample was further 
homogenized with 1 ml C H 3 C N . For recovery experiments 10 ul C y A 
stock solution were added with this first C H 3 C N portion. The homogenate 
was transferred into a 4 ml vial using Pasteur pipette, the vial was centri-
fuged at 1000 g for 3 min. The supernatant was transferred using another 
Pasteur pipette into a 5 ml PE syringe and immediately passed through a 
0.2 urn filter into a scaled 10 ml centrifuge tube. 
Mortar and pestle were washed with 1 ml C H 3 C N , the liquid was trans-
ferred to the sediment and the vial was vortexed for 30 s and centrifuged 
for 3 min at 1000 g. The supernatant was filtered into the centrifuge tube 
and the wash step was repeated using sonication instead of vortexing. 
The combined filtrate was evaporated on a 50°C water bath by a N 2 
stream to 0.3 ml volume, and by slow vortexing 0.9 ml water were added; 
the sample became slightly opalescent. 
Preparative HPLC 
Equipment 
H P L C pump: model 6000 A (Millipore-Waters, Eschborn), equipped on 
the outlet with a cleaning precolumn 4 x 60 mm dry-packed with 12-20 
\im PRP-1 (Hamilton, Reno).- Injector: model U 6 K (Millipore-Waters) 
with 2 ml loop.- Preparative column: A cartridge 4 x 20 mm filled with 5 
jxm Spherisorb Alumina PC-18 (Bischoff Analysentechnik, Leonberg) was 
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Fig. 1: Fluid system of the preparative Chromatograph. 
thermostated to 75°C. Mobile phase:CH 3 CN-H 2 0 29:71 with NaOH addi-
tion up to 0.2 mmol/1 total concentration, flow rate 2 ml/min.- Trap: 4 x 30 
mm dry-packed with 12-20 um PRP-1, switched by Rheodyne 7000 vent.-
U V detector: SpectroMonitor 3200 (LDC Analytical GmbH, Gelnhausen), 
detection wavelength 212 nm, I V output, range 1AU, response time 5 s 
(Fig. 1).- Integrator: DataJet (Spectra-Physics, Darmstadt), attenuation 2 
mV/full scale, with the option of postrun integration ( L A B N E T assisted by 
an A C E R 910 personal computer). 
Sample collection 
The C y A analytical window was checked by injection of a mixture of 
approximately 100 ul C y A stock solution + 0.2 ml C H 3 C N + 0.9 ml H 2 0 + 
0.2 ml mobile phase. Sample analysis was done with an identical mobile 
phase. The sample was filled into the injector loop and the centrifugation 
tube was washed with 0.2 ml mobile phase, shortly vortexed with maximal 
intensity, and shortly centrifuged. The washing liquid was also filled into 
the injector loop and the whole sample was injected. In the C y A elution 
interval the trap was switched on. 
Trap handling 
After sampling has been completed, the trap was washed with 1 ml H 2 0 , 
approx. 1 min blown with N 2 and eluted in the opposite direction with 0.5 
ml C H 3 C N . The effluent was evaporated to dryness on a water bath at 
50°C with a N 2 stream. It was usefull to continue the N 2-blowing for furt-
her 10 min so that the amount of volatile contaminants originated from 
C H 3 C N was reduced. The C y A recovery was not affected thereby. The 
residue was analysed by R P - H P L C . 
Column and trap washing 
After analysis the preparative column was washed at 75°C in the oppo-
site direction together with the cleaning column at room temp, successive-
ly with 50 ml C H 3 C N , 50 ml C H 3 C N - H 2 0 1:1 with NaOH addition up to 
0.2 mmol N a O H total concentration, and 50 ml C H 3 C N . The trap was 
washed in the opposite direction at room temp, with 50 ml C H 3 C N and 0.5 
ml H 2 0 . 
Reversed-phase analytical HPLC 
Equipment 
HPLC pump: model 6000 A (Millipore-Waters). 
A guard column 4 x 60 mm dry-packed with 37-50 um Bondapak C-18 
Corasil (Millipore-Waters) was thermostated to 70°C. It was followed by 
an analytical pre- and main column 4 x 20 + 250 mm filled with 5 urn 
Spherisorb ODS II (Bischoff-Analysentechnik, GmbH), thermostated to 
70°C. Mobile phase: H C H 3 C N - H 2 0 71:29, flow rate 1.2 ml/min.- Injector: 
model 7125 (Rheodyne, Berkeley) with 0.5 ml loop.- For U V detector and 
integrator see Preparative HPLC- Integrator attenuation 1 mV/full scale. 
Calibration 
10 ul C y A stock solution (external standard) and 150 ul mobile phase 
were introduced into a vial and vortexed for 30 s, simulating the conditions 
for sample analysis. The solution was sucked into a 250 ul syringe. 100 ul 
mobile phase were used to wash the vial, sucked into the syringe and the 
complete sample was injected. To ensure higher determination accuracy 
the standard injection was repeated for at least three times. The medium 
C y A retention volume and the average calibration factor were determined 
from these chromatograms. 
Sample analysis 
The sample residue of the preparative collection was reconstituted ana-
logously to the standard. During its analysis on the R P - H P L C analytical 
column the detector effluent was collected in the interval of the C y A ana-
lytical window, 10 pi CyC stock solution were added, and the effluent was 
immediately evaporated to dryness on a water bath at 50°C by a N 2 stream. 
The residue was reanalysed in the following step. 
Normal-phase HPLC 
Equipment 
HPLC-pump: model 114 M (Beckman Instruments, Munich).- Pre- and 
main column 4 x 20 + 250 mm were filled with 5 um Hypersil CPS (cya-
nopropylsilica, Bischoff Analysentechnik GmbH) and thermostated at 
75°C. Mobile phase: 10% isopropanol in hexane, flow rate 1 ml/min.-
Injector, detector, and integrator see RP-HPLC. 
The sample evaporated after R P - H P L C together with C y C as internal 
standard was sonicated for 10 min with 2 ml C H 3 C N in order to release the 
cyclosporine molecules adsorbed on the glass and the solution was evapo-
rated to dryness on a water bath at 50°C by a N 2 stream. The residue was 
reconstituted in 250 ul 15% /-PrOH/hexane by 1 min vortexing and 3 min 
sonication and the solution was injected; the vial was not washed. 
Results and Discussion 
Both analytical and the preparative column were main-
tained at 70-75°C in order to accelerate the interconversion 
of the C y A conformers5) and so to prevent peak broadening. 
Preparative HPLC 
The presented procedure requires a high degree of purity 
of all solvents and materials especially on account of work-
ing with a trap. 
C H 3 C N of various qualities and of various origins was 
checked for impurities. In all lots three contaminants were 
found which, however, did not interfere with CyA. LiChro-
solv water contained only a small quantity of a substance 
eluted in the C y A vicinity. By preparative H P L C it was 
possible to remove most of the mentioned contaminants 
using a short cleaning PRP-1 pre-column connected to the 
pump outlet. 
Most of the skin matrix substances were found to be of 
acidic character. On a preparative octadecylsilane column 
with an acidic mobile phase they were strongly retained and 
H P L C of Cyclosporine A in Skin 
the peaks were tailing as compared to neutral conditions. In 
these both cases, however, the C y A peak was overlapped 
by the skin matrix peaks. Only the application of an alka-
line mobile phase and an alkaline-resistant sorbent (PRP-1 
or Spherisorb Alumina PC-18) enabled the required separa-
tion (Fig. 2). 
The preparative chromatography of the skin matrix was 
satisfactory provided only upper skin layer (epidermis and 
dermis) were taken. By analysis of the samples containing 
deeper skin layers or subcutaneous tissue the separation 
was not reliable and relative large peaks appeared in the 
C y A window (probably lipids). 
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Fig. 2: Preparative H P L C of 10 ng C y A spiked skin extract. The fraction 
between the two dashed lines was collected and analysed by R P - H P L C . 
Reversed-phase HPLC 
Typical chromatograms obtained from C y A spiked skin 
and a sample from a psoriatic patient are shown in Fig. 3. 
If the C y A analytical window and its vicinity are free of 
interfering peaks CyA can be determined down to concen-
tration of 0.5 ng using CyC as an internal standard. Howev-
er, in some separations of thicker upper skin layers taken by 
lancet the result can be affected by fusion of the internal 
standard peak with some relative great impurity peaks. 
Because CyA recovery was almost quantitative in the given 
case the external standard method seems to be just as reli-
able. 
The recovery was extensively checked on the 10 ng level: 
it amounts to 101.3% (mean of 3 determinations, RSD 
1.1%) without skin addition and 96.8% (mean of 6 determi-
nations, RSD 6.3%) by the complete analysis of spiked 
skin samples. 
The sensitivity of the analytical RP-HPLC was relatively 
high. By injection of 0.94 ng C y A the signal/noise ratio was 
27. It should be theoretically possible to determine less than 
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0.5 ng C y A , i f all the substances out of the skin matrix 
could be removed in a nearly quantitative way. Otherwise 
the 3 ng CyA/sample must be considered as the lowest limit 
for reliable determination. 
This work was done in cooperation with the Department 
of Dermatology of the University of Cologne; three skin 
samples were supplied taken by biopsy from psoriatic 
patients. A C y A content was found therein from 1 to 6 
ng/mg wet tissue. 
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Fig. 3: R P - H P L C of purified skin extracts. (A) 10 ng C y A spiked epider-
mis. (B) Skin biopsy of C y A treated psoriatic patient, app. 1 mm upper 
layer. The impurities originating from C H 3 C N are marked with crosses. 
Normal-phase HPLC 
When the skin matrix separation by preparative H P L C 
was insufficient and, therefore, the RP-HPLC determination 
was not reliable, it was possible to carry out an additional 
analysis with the collected CyA-effluent out of the RP-
H P L C column by its reinjection (after proper treatment) 
into the normal-phase H P L C system6). Preliminary experi-
ments using a cyanopropylsilica column and 10% isopro-
panol in hexan as mobile phase gave promissing results. 
Five standard analyses were carried out to prove the 
recovery of this step: each time 10 | i l of C y A and C y C 
stock solutions were mixed with approximately 2 ml mobile 
phase collected behind the analytical RP-HPLC column and 
this simulated effluent was treated previous to injection like 
a true sample. 
The recoveries of both cyclosporines ranged approximate-
ly from 75% to 90% compared to the direct standard injec-
tions of the same amounts of C y A and C y C in 15% i-
PrOH/hexane but the peak areas ratio CyA/CyC was con-
stant (mean 1.022, RSD 4.3%), which made the internal 
standard method usable. 
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Fig. 4: Reversed- and normal-phase H P L C of not satisfactorily purified 10 
ng C y A spiked skin extract. (A) R P - H P L C , recovery 102%. The fraction 
between the two dashed lines was collected and re-analyzed by N P - H P L C 
(B), recovery 101%. 
Quantitative recoveries were achieved using fresh 2 ml 
R P - H P L C analytical mobile phase instead of the one 
collected behind the column. At 75°C the surface of the 
modified silica is relatively strongly degraded and the 
released octadecylsilanol molecules create a hydrophobic 
cover on the glass wall, which can bind cyclosporine. 
Three complete spiked skin analyses including all three 
H P L C steps were performed with satisfactory results. C y A 
amounts calculated on the base of the normal-phase H P L C 
ranged from 94% to 103% (mean 99.3%, RSD 4.8%). Ana-
lytical chromatograms of one of these analyses are shown 
in the Fig. 3. 
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